Valiant Laboratories (BOM:543998) Change In Receivables : ₹0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2023. Start your Free Trial

What is Valiant Laboratories Change In Receivables?

Valiant Laboratories's change in receivables for the quarter that ended in Mar. 2025 was ₹0 Mil. It means Valiant Laboratories's Accounts Receivable stayed the same from Dec. 2024 to Mar. 2025 .

Valiant Laboratories's change in receivables for the fiscal year that ended in Mar. 2025 was ₹-273 Mil. It means Valiant Laboratories's Accounts Receivable increased by ₹273 Mil from Mar. 2024 to Mar. 2025 .

Valiant Laboratories's Accounts Receivable for the quarter that ended in Mar. 2025 was ₹721 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Valiant Laboratories's Days Sales Outstanding for the three months ended in Mar. 2025 was 113.89.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Valiant Laboratories's liquidation value for the three months ended in Mar. 2025 was ₹-345 Mil.

Valiant Laboratories Change In Receivables Historical Data

The historical data trend for Valiant Laboratories's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valiant Laboratories Change In Receivables Chart

Valiant Laboratories Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Mar25

Change In Receivables

-207.01

-682.72

215.08

428.81

-272.74

Valiant Laboratories Quarterly Data
	Mar21	Mar22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Receivables	Get a 7-Day Free Trial								-	-	-	-	-

Valiant Laboratories Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

Valiant Laboratories (BOM:543998) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Valiant Laboratories's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	721.219	/	577.858	*	91
=	113.89

2. In Ben Graham's calculation of liquidation value, Valiant Laboratories's accounts receivable are only considered to be worth 75% of book value:

Valiant Laboratories's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	759.914	-	1665.474	+	0.75 * 721.219	+	0.5 * 39.887
=	-345

Valiant Laboratories Change In Receivables Related Terms

Thank you for viewing the detailed overview of Valiant Laboratories's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Valiant Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Valiant Laboratories Ltd (BOM:543998) » Definitions » Change In Receivables

Traded in Other Exchanges

VALIANTLAB:India

Address

Mulund Goregaon Link Road, 104, Udyog Kshetra, Mulund, MH, IND, 400080

Website

https://www.valiantlabs.in

Valiant Laboratories Ltd is an Active Pharmaceutical Ingredient (API)/Bulk Drug manufacturing company with having focus on manufacturing Paracetamol. Paracetamol is one of the widely used analgesics globally and is recommended as the first-line therapy in pain conditions by the World Health Organization. Paracetamol has several applications such as usage in the treatment of headaches, muscle aches, arthritis, backaches, toothaches, colds, and fever. It manufactures Paracetamol in various grades such as IP/BP/EP/USP, as per the pharmacopeia requirements of its customers.

Valiant Laboratories Headlines

No Headlines